Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Promoter-for-neuropeptide-FF-and-use-thereof-for-therapy-and-diagnostics

 Electrophoretic method for the isolation and separation of microorganisms and cell populations
It is an object of the invention to provide a novel electrophoretic method for the separation of ...


 Human antithrombin III
The present invention is directed to the means and methods of producting human antithrombin III via ...


 Cryptophycins
OF THE INVENTION The present invention provides novel cryptophycin compounds having the following ...


 Method for recovery of refined .alpha.-galactosidase
OF THE INVENTION The methods heretofore suggested for the refinement of .alpha.-galactosidase ...


 Antimicrobial composition containing Type II endoglycosidase and antimicrobial agent
The invention provides antimicrobial methods utilizing Type II endoglycosidases such as endo-.beta.-...


 Wound healing composition of IGF-I and TGF-.beta.
We claim: 1. A method for healing an external wound of a mammal comprising applying to said wound a ...


 Flowable demineralized bone powder composition and its use in bone repair
What is claimed is: 1. A flowable composition for application to a bone defect site to promote new ...


 Crosslinkable polypeptide compositions
OF THE INVENTION In accordance with the present invention, there are provided chemically modified ...


 Promoter for neuropeptide FF and use thereof for therapy and diagnostics

Details
Inventors: Panula, Pertti Aarre Juhani; Brandt, Annika; Westerlund, Johanna;
Assignee:
Primary Examiner: Ketter; James
Assistant Examiner: Gansheroff; Lisa
Attorney, Agent or Firm: Rothwell, Figg, Ernst & Manbeck

The present invention relates to isolating, sequencing and cloning of the 5'-flanking region of neuropeptide FF (NPFF) promoter. The characterized neuropeptide FF (NPFF) promoter is useful in gene therapy and in DNA analyses, and in production of gene-modified animals.

DETAILED DESCRIPTION OF THE INVENTION We report here the cloning of the 5'-flanking region of the NPFF gene from mouse, rat and human.
Totally 9.
8 kb, 1.
5 kb and 1.
3 kb of the NPFF promoter from mouse, rat and human was cloned and sequenced.
Comparisons between the promoter region from all species showed a high sequence similarity.
Such a high sequence homology and well-conserved structure could indicate an important physiological function and a need for a similar, tightly regulated transcription of the gene.
We have previously shown that the NPFF gene is expressed in specific regions in the brain and in the spinal cord and is induced upon inflammatory stimulus (Vilim et al.
, 1999).
In agreement with this several inflammation related transcription factor consensus sites were found (FIG.
1B), amongst them e.
g.
NF.
kappa.
B, which is considered as an immediate early mediator of immune and inflammatory responses (Lenardo & Baltimore, 1989).
Also several consensus sites for the nuclear factor of activated T-cells (NFAT) were found (for review see Kel et al.
, 1999).
Transcription factors belonging to this growing family play key roles in the regulation of cytokine and other genes during immune response.
An interesting finding was also the consensus site in mouse and rat for heat shock factor 1 (HSF1).
HSF1 is activated in cells exposed to elevated temperatures and other environmental stress conditions (Sarge et al.
, 1993).
We also focused on the potential involvement of AP1, STAT1 and CREB.
By using transiently transfected cells with deletional series of mouse NPFF promoter fused with firefly luciferase cDNA we could show that the basal activity of the promoter changes with increasing promoter size (FIG.
2B).
This indicates that the promoter is tightly regulated is affected by several transcriptional factors and apparently has a complex transcriptional control.
To study the possible involvement of some transcription factors our attempt was to a) activate transcription factors by protein kinase C (PKC) b) activate NFATp by PKC and Ca



Related patents
  Transcriptional activators, and compositions and uses related thereto
OF THE INVENTION I. General Protein-encoding genes in eukaryotes are transcribed by RNA polymerase II (pol II), a multisubunit enzyme that is brought to an appropriate ...
  Diagnostic probes for pneumocystis carini
OF THE INVENTION This invention relates to a method for diagnosing for Pneumocystis carinii by detecting the presence of a nucleic acid sequence containing the 26S rRNA ...
  Peanut allergens and methods
OF THE INVENTION In accordance with a preferred embodiment of the present invention, a monoclonal antibody (MAb) based enzyme-linked immunosorbent assay (ELISA) and ...
  Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products
OF THE INVENTION Applicants' invention provides a simplified method for isolating primer extension products from template-directed DNA polymerase reactions. For the ...
  Comparative genomic hybridization (CGH)
Comparative Genomic Hybridization (CGH) has also been termed Copy Ratio Reverse Cytogenetics (CRRC), competition hybridization and quantitative in situ ratio ...
  DNA sequence-based HLA typing method
The present invention relates to a method for determining the nucleic acid sequence of one or more polymorphic genes of a subject by amplifying and direct sequencing ...
  Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
OF THE INVENTION The present invention relates to alterations in the KVLQT1, HERG, SCN5A, KCNE1 and KCNE2 genes and methods for detecting such alterations. The ...
  Method for forming image
OF THE INVENTION In accordance with the present invention there is provided a method for processing a silver halide color photographic material that has silver halide ...
  WF11243 substance
We claim: 1. An isolated compound having formula (I): ##STR4## or a salt thereof. 2. A method for producing a compound of formula (I): ##STR5## or a salt thereof which ...
  Plant virus vector, plasmid, process for expression of foreign gene and process for obtaining foreign gene product
The purpose of the present invention is to provide plant virus vectors having the ability to systemically infect a whole plant; plasmids, which are transcribed to ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved